Skip to main content
Connect with Us
GDPR
Login for Member Access
Search form
Home
About Us
Membership
Chicago 2023
Past Meetings
Berlin 2022
Chicago 2022
Autumn 2021
Spring 2021
Autumn 2020
Spring 2020
Athens 2019
Chicago 2019
Munich 2018
Chicago 2018
Vienna 2017
Chicago 2017
Lisbon 2016
Chicago 2016
Japan 2015
Chicago 2015
Melbourne 2014
Chicago 2014
London 2013
Chicago 2013
Leiden 2012
Chicago 2012
Milan 2011
Calendar
Event Listing
GCIG Clinical Trials
Bibliography
CCRN Committee
GCIG CCRN Education Symposium, Johannesburg, January 2019
GCIG CCRN Education Symposium, Bucharest, January 2018
GCIG CCRN Education Symposium, Mexico, January 2017
GCIG CCRN Education Symposium, Bangkok, January 2016
Educational Symposia
Harmonization
Resources
Home
/
GOG 0275
GOG 0275
Trial Description:
Dactinomycin or Methotrexate in Treating Patients with Low Risk Gestational Trophoblastic Neoplasia
Lead Cooperative Group:
GOG
Trial Number:
ClinicalTrials.gov Identifier: NCT01535053
Disease Site:
Gestational Trophoblastic Neoplasia
Trial Status:
Recruiting
